Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

EPA:EXPL - Euronext Paris - Matif - FR0014003AQ4 - Common Stock - Currency: EUR

191.5  -3 (-1.54%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXPL. EXPL was compared to 69 industry peers in the Chemicals industry. EXPL scores excellent on profitability, but there are some minor concerns on its financial health. EXPL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year EXPL was profitable.
EXPL had a positive operating cash flow in the past year.
Of the past 5 years EXPL 4 years were profitable.
Each year in the past 5 years EXPL had a positive operating cash flow.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

EXPL's Return On Assets of 4.98% is fine compared to the rest of the industry. EXPL outperforms 71.01% of its industry peers.
EXPL's Return On Equity of 14.04% is fine compared to the rest of the industry. EXPL outperforms 78.26% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.36%, EXPL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXPL is in line with the industry average of 6.66%.
The 3 year average ROIC (6.01%) for EXPL is below the current ROIC(6.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

EXPL's Profit Margin of 4.77% is fine compared to the rest of the industry. EXPL outperforms 63.77% of its industry peers.
In the last couple of years the Profit Margin of EXPL has grown nicely.
EXPL has a Operating Margin (4.22%) which is in line with its industry peers.
In the last couple of years the Operating Margin of EXPL has grown nicely.
Looking at the Gross Margin, with a value of 60.41%, EXPL belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
In the last couple of years the Gross Margin of EXPL has grown nicely.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPL is destroying value.
EXPL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXPL has more shares outstanding
EXPL has a better debt/assets ratio than last year.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPL has an Altman-Z score of 2.65. This is not the best score and indicates that EXPL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.65, EXPL is doing good in the industry, outperforming 65.22% of the companies in the same industry.
EXPL has a debt to FCF ratio of 2.38. This is a good value and a sign of high solvency as EXPL would need 2.38 years to pay back of all of its debts.
The Debt to FCF ratio of EXPL (2.38) is better than 91.30% of its industry peers.
EXPL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
EXPL has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.65
ROIC/WACC0.86
WACC7.41%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.26 indicates that EXPL should not have too much problems paying its short term obligations.
The Current ratio of EXPL (1.26) is worse than 78.26% of its industry peers.
EXPL has a Quick Ratio of 1.26. This is a bad value and indicates that EXPL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EXPL (0.94) is worse than 63.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.64% over the past year.
The Earnings Per Share has been growing by 51.47% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.64% in the past year.
Measured over the past years, EXPL shows a small growth in Revenue. The Revenue has been growing by 7.27% on average per year.
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%

3.2 Future

EXPL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.28% yearly.
The Revenue is expected to grow by 3.63% on average over the next years.
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

EXPL is valuated rather expensively with a Price/Earnings ratio of 17.35.
Based on the Price/Earnings ratio, EXPL is valued a bit cheaper than 68.12% of the companies in the same industry.
When comparing the Price/Earnings ratio of EXPL to the average of the S&P500 Index (26.35), we can say EXPL is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.08, the valuation of EXPL can be described as correct.
Based on the Price/Forward Earnings ratio, EXPL is valued a bit cheaper than 65.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, EXPL is valued a bit cheaper.
Industry RankSector Rank
PE 17.35
Fwd PE 13.08
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXPL.
85.51% of the companies in the same industry are more expensive than EXPL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.66
EV/EBITDA 10.56
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXPL's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y21.01%
EPS Next 3Y17.28%

More info and screens

2

5. Dividend

5.1 Amount

EXPL has a yearly dividend return of 0.77%, which is pretty low.
Compared to an average industry Dividend Yield of 3.04, EXPL is paying slightly less dividend.
With a Dividend Yield of 0.77, EXPL pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

9.03% of the earnings are spent on dividend by EXPL. This is a low number and sustainable payout ratio.
DP9.03%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

More info and screens

EXPLOSIFS PROD. CHI

EPA:EXPL (6/20/2025, 7:00:00 PM)

191.5

-3 (-1.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.7%
Inst Owner ChangeN/A
Ins Owners10.85%
Ins Owner ChangeN/A
Market Cap432.79M
Analysts42.22
Price Target221.34 (15.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 17.35
Fwd PE 13.08
P/S 0.88
P/FCF 10.66
P/OCF 6.45
P/B 2.6
P/tB 2.89
EV/EBITDA 10.56
EPS(TTM)11.04
EY5.77%
EPS(NY)14.64
Fwd EY7.64%
FCF(TTM)17.96
FCFY9.38%
OCF(TTM)29.69
OCFY15.5%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexcg growth 3Y2.1%
ROICexcg growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.65
F-Score6
WACC7.41%
ROIC/WACC0.86
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year87.74%
EBIT Next 3Y32.42%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%